Almac Discovery
Next Generation Therapeutics
Delivering First-in-Class and Best-in-Class next generation therapeutics by leveraging
our integrated expertise in protein engineering and small molecule drug discovery
Fearless Innovation
At Almac Discovery, scientific innovation and relentless
curiosity drives our ambition to develop next generation ADCs
and small molecules that will improve patients’ lives well into
the future.
Science Drives Our Mission
Explore our pipeline of highly innovative therapeutics for
oncology, cardiometabolic disorders and neurodegeneration.
wide-content
no-arc
Our Research
Latest from Almac Discovery
News 06/05/2025
Almac Discovery and Formosa Pharmaceuticals announce global licensing agreement for development and commercialisation of ALM-401, a first-in-class EGFRxROR1 Bispecific Antibody-Drug Conjugate
News 06/06/2023
WEE1 Inhibitor discovered by Almac Discovery advanced into two clinical studies addressing the treatment of advanced solid tumours